在地平线上有希望:D型肝炎的新兴疗法
1Department of Hepatogastroenterology, Dr. Ziauddin University Hospital Clifton, Karachi 75600, Sindh, Pakistan. drzabbas@gmail.com.
World journal of hepatology
|July 3, 2025
概括
新的乙型肝炎病毒 (HDV) 治疗方法显示出超出有限选择的前景. 新兴疗法,包括进入抑制剂和组合治疗,为改善患者的治疗结果和病毒反应提供了希望.
科学领域:
- 肝病学和病毒学.
- 药物开发 药物开发
- 传染性疾病 传染性疾病
背景情况:
- 目前的乙型肝炎病毒 (HDV) 治疗选择有限,基化干扰素-α (PEG-IFNα) 提供有限的疗效和显著的副作用.
- 基化干扰素兰巴达向肝细胞上的III型受体,而布莱维尔提德通过NTCP受体抑制病毒的进入.
研究的目的:
- 审查慢性肝炎D的当前和新兴治疗策略.
- 突出新药候选药物和临床开发中的组合疗法.
主要方法:
- 对最近批准的和正在研究的HDV药物的审查.
- 对新药和组合疗法早期临床试验数据的分析.
主要成果:
- 布列维尔提德已在欧盟/俄罗斯批准用于慢性HDV.
- 新的病毒入抑制剂 (HH003,tobevibart),核酸聚合物 (REP 2139-Mg),前化抑制剂 (lonafarnib) 和RNA干扰剂 (elebsiran) 正在开发中.
- 第二阶段SOLSTICE试验显示,24周后,tobevibart/elebsiran联合治疗的病毒学和生化反应>50%.
结论:
- 新兴疗法,包括进入抑制剂和组合治疗,为改善型肝炎管理提供了显著的希望.
- 在正在进行的试验中进行进一步的评估 (ECLIPSE 1,2,3) 对于确定这些新型HV治疗方法的有效性和安全性至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
360
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
360
Retrovirus Life Cycles
47.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.0K


